Intraperitoneal vs Intravenous Chemotherapy Following Neoadjuvant Chemotherapy in Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Cisplatin
Related studies linked through entity extraction aliases.
Carboplatin, Paclitaxel, Bevacizumab, and Veliparib in Treating Patients With Newly Diagnosed Stage II-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Combined Modality Treatment for Resectable Non-Small Cell Superior Sulcus Tumors
- Status
- COMPLETED
- Phase
- PHASE2
First-line Treatment of Patients With Stage IV Nonsquamous Non-Small Cell Lung Cancer With Necitumumab (IMC-11F8) and Pemetrexed-Cisplatin
- Status
- COMPLETED
- Phase
- PHASE3
Radiation Therapy and Chemotherapy in Treating Patients With Stage I Bladder Cancer
- Status
- COMPLETED
- Phase
- PHASE2
First-line Treatment of Participants With Stage IV Squamous Non-Small Cell Lung Cancer With Necitumumab and Gemcitabine-Cisplatin
- Status
- COMPLETED
- Phase
- PHASE3
Chemotherapy and Pelvic Radiation Therapy With or Without Additional Chemotherapy in Treating Patients With High-Risk Early-Stage Cervical Cancer After Radical Hysterectomy
- Status
- COMPLETED
- Phase
- PHASE3
Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer
- Status
- COMPLETED
- Phase
- PHASE3
A Study of the Safety and Pharmacology Of PI3-Kinase Inhibitor GDC-0941 In Combination With Either Paclitaxel And Carboplatin (With or Without Bevacizumab) or Pemetrexed, Cisplatin, And Bevacizumab in Patients With Advanced Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Cisplatin, Temozolomide, Abraxane, With Interleukin-2 and Interferon for Metastatic Melanoma
- Status
- COMPLETED
- Phase
- PHASE1
Hyperthermic Intraoperative Intraperitoneal Chemotherapy of Recurrent Ovarian Cancer - A Feasibility Study
- Status
- TERMINATED
- Phase
- NA
Everolimus Dose Finding Study for Stage IV or Recurrent Cervical Cancer
- Status
- WITHDRAWN
- Phase
- PHASE1
Cisplatin, Capecitabine, Gemcitabine and Epirubicin or Docetaxel for Patients With Stage III or IV Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Paclitaxel and Cisplatin as First-Line Treatment for Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
A Comparison of FLT to FDG PET/CT in the Early Assessment of Chemotherapy Response in Stage IB-IIIA Resectable NSCLC
- Status
- COMPLETED
- Phase
- PHASE2
AVAPERL1 Study: A Study of Avastin (Bevacizumab) With or Without Pemetrexed as Maintenance Therapy After Avastin in First Line in Patients With Non-Squamous Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Study of Cediranib Plus Cisplatin Plus Capecitabine/S-1 in Japanese Gastric Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE1
Gemcitabine or Combination Chemotherapy Followed by Chemoradiation for Stage IB, II, or III Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Radiation Therapy and Cisplatin With or Without Cetuximab in Treating Patients With Stage IB, Stage II, or Stage IIIB Cervical Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Radiation Therapy, Cisplatin, Fluorouracil, and Cetuximab in Treating Patients With Locally Advanced Anal Cancer
- Status
- TERMINATED
- Phase
- PHASE2